Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHASE-I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 4433 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laheru, D; Biedrzycki, B; Jaffee, EM
      Immunologic approaches to the management of pancreatic cancer

      CANCER JOURNAL
    2. McGinn, CJ; Zalupski, MM
      Combined-modality therapy in pancreatic cancer: Current status and future directions

      CANCER JOURNAL
    3. Howell, SB
      Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam (TM) technology

      CANCER JOURNAL
    4. Garderet, L; Cao, H; Salamero, J; Verge, V; Tisserand, E; Scholl, S; Gorin, NC; Lopez, M
      In vitro production of dendritic cells from human blood monocytes for therapeutic use

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Chen, J; Zhou, JH; Ball, ED
      Characterization of a new monoclonal antibody 6G7 that recognizes a uniqueantigen on myeloid and lymphoid cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    6. van de Wijgert, J; Fullem, A; Kelly, C; Mehendale, S; Rugpao, S; Kumwenda, N; Chirenje, Z; Joshi, S; Taha, T; Padian, N; Bollinger, R; Nelson, K
      Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Singh, S; Cunningham, C; Buchanan, A; Jolly, DJ; Nemunaitis, J
      Toxicity assessment of intratumoral injection of the herpes simplex type Ithymidine kinase gene delivered by retrovirus in patients with refractory cancer

      MOLECULAR THERAPY
    8. Rahman, A; Tsai, V; Goudreau, A; Shinoda, JY; Wen, SF; Ramachandra, M; Ralston, R; Maneval, D; LaFace, D; Shabram, P
      Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy

      MOLECULAR THERAPY
    9. Nakano, M; Aoki, K; Matsumoto, N; Ohnami, S; Hatanaka, K; Hibi, T; Terada, M; Yoshida, T
      Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA

      MOLECULAR THERAPY
    10. Harvey, BG; Hackett, NR; Ely, S; Crystal, RG
      Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals

      MOLECULAR THERAPY
    11. Sawai, N; Zhou, S; Vanin, EF; Houghton, P; Brent, TP; Sorrentino, BP
      Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector

      MOLECULAR THERAPY
    12. Dinndorf, P; Krailo, M; Liu-Mares, W; Frierdich, S; Sondel, P; Reaman, G
      Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemiaand lymphoma

      JOURNAL OF IMMUNOTHERAPY
    13. June, CH
      Can't get any help? New approaches for adoptive immunotherapy of cancer

      JOURNAL OF IMMUNOTHERAPY
    14. Karanikas, V; Thynne, G; Mitchell, P; Ong, CS; Gunawardana, D; Blum, R; Pearson, J; Lodding, J; Pietersz, G; Broadbent, R; Tait, B; McKenzie, IFC
      Mannan mucin-1 peptide immunization: Influence of cyclophosphamide and theroute of injection

      JOURNAL OF IMMUNOTHERAPY
    15. Bodell, WJ; Giannini, DD; Hassenbusch, S; Levin, VA
      Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors

      NEURO-ONCOLOGY
    16. Jorgensen, TJ; Katz, S; Wittmack, EK; Varghese, S; Todo, T; Rabkin, SD; Martuza, RL
      Ionizing radiation does not alter the antitumor activity of herpes simplexvirus vector G207 in subcutaneous tumor models of human and murine prostate cancer

      NEOPLASIA
    17. Zeh, HJ; Stavely-O'Carroll, K; Choti, MA
      Vaccines for colorectal cancer

      TRENDS IN MOLECULAR MEDICINE
    18. Gunzburg, WH; Salmons, B
      Novel clinical strategies for the treatment of pancreatic carcinoma

      TRENDS IN MOLECULAR MEDICINE
    19. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    20. Brinkmann, U; Keppler-Hafkemeyer, A; Hafkemeyer, P
      Recombinant immunotoxins for cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    21. Morse, MA; Clay, TM; Hobeika, AC; Mosca, PJ; Lyerly, HK
      Surrogate markers of response to cancer immunotherapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    22. Alavi, JB; Eck, SL
      Gene therapy for high grade gliomas

      EXPERT OPINION ON BIOLOGICAL THERAPY
    23. Rochlitz, CF
      Gene therapy of cancer

      SWISS MEDICAL WEEKLY
    24. Zouboulis, CC
      Retinoids - Which dermatological indications will benefit in the near future?

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    25. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    26. Nicolau, JC; Serrano, CV; Garzon, SAC; Ramires, JAF
      Prognosis of acute myocardial infarction in the thrombolytic era: medical evaluation is still valuable

      EUROPEAN JOURNAL OF HEART FAILURE
    27. Zagotto, G; Gatto, B; Moro, S; Sissi, C; Palumbo, M
      Anthracyclines: recent developments in their separation and quantitation

      JOURNAL OF CHROMATOGRAPHY B
    28. Adjei, AA
      Ras signaling pathway proteins as therapeutic targets

      CURRENT PHARMACEUTICAL DESIGN
    29. Frenkel, GD; Caffrey, PB
      A prevention strategy for circumventing drug resistance in cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    30. Jung, LL; Zamboni, WC
      Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

      DRUG RESISTANCE UPDATES
    31. Matter, A
      Tumor angiogenesis as a therapeutic target

      DRUG DISCOVERY TODAY
    32. Akkerhuis, KM; van den Brand, MJBM; van der Zwaan, C; Peels, HOJ; Suryapranata, H; van der Wieken, LR; Stibbe, J; Hoffmann, J; Baardman, T; Deckers, JW; Simoons, ML
      Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty

      HEART
    33. Marchini, S; Broggini, M; Sessa, C; D'Incalci, M
      Development of distamycin-related DNA binding anticancer drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    34. Midgley, R; Kerr, D
      Conventional cytotoxic and novel therapeutic concepts in colorectal cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    35. Johnston, SRD; Kelland, LR
      Farnesyl transferase inhibitors - a novel therapy for breast cancer

      ENDOCRINE-RELATED CANCER
    36. Johnson, PWM
      The therapeutic use of antibodies for malignancy

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    37. Chen, MJ; Chung-Faye, GA; Searle, PF; Young, LS; Kerr, DJ
      Gene therapy for colorectal cancer - Therapeutic potential

      BIODRUGS
    38. Frankel, AE; Schuster, MW; Jurcic, JG
      Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

      BIODRUGS
    39. Coze, C; Leimig, T; Jimeno, MT; Mannoni, P
      Retrovirus-mediated gene transfer of the cytokine genes interleukin-1 betaand tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties

      EUROPEAN CYTOKINE NETWORK
    40. Davies, JC; Geddes, DM; Alton, EWFW
      Gene therapy for cystic fibrosis

      JOURNAL OF GENE MEDICINE
    41. Henson, KL; Stauffer, G; Gallagher, EP
      Induction of glutathione S-transferase activity and protein expression in brown bullhead (Ameiurus nebulosus) liver by ethoxyquin

      TOXICOLOGICAL SCIENCES
    42. Georgopoulos, PG; Roy, A; Yonone-Lioy, MJ; Opiekun, RE; Lioy, PJ
      Environmental copper: Its dynamics and human exposure issues

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
    43. Evans, DB
      Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas

      JOURNAL OF GASTROINTESTINAL SURGERY
    44. Velan, SS; Narasimhan, PT; Jacobs, RE
      MR imaging with phase encoding of intermolecular multiple quantum coherences

      JOURNAL OF MAGNETIC RESONANCE
    45. Dalakas, MC
      Peripheral neuropathy and antiretroviral drugs

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    46. Buchsbaum, DJ; Curiel, DT
      Gene therapy for the treatment of cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    47. Crombet, T; Torres, O; Neninger, E; Catala, M; Rodriguez, N; Ramos, M; Fernandez, E; Iznaga, N; Perez, R; Lage, A
      Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    48. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    49. Khan, SA; Gaa, B; Pollock, BH; Shea, B; Reddy, V; Wingard, YR; Moreb, JS
      Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    50. Friedberg, JW; Neuberg, D; Monson, J; Jallow, H; Nadler, LM; Freedman, AS
      The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    51. Boeckh, M; Bowden, RA; Storer, B; Chao, NJ; Spielberger, R; Tierney, DK; Gallez-Hawkins, G; Cunningham, T; Blume, KG; Levitt, D; Zaia, JA
      Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    52. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    53. Bruno, B; Gooley, T; Sullivan, KM; Davis, C; Bensinger, WI; Storb, R; Nash, RA
      Secondary failure of platelet recovery after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    54. Kramer, G; Steiner, GE; Sokol, P; Handisurya, A; Klingler, HC; Maier, U; Foldy, M; Marberger, M
      Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    55. Kirn, D; Martuza, RL; Zwiebel, J
      Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

      NATURE MEDICINE
    56. Bennett, JJ; Tjuvajev, J; Johnson, P; Doubrovin, M; Akhurst, T; Malholtra, S; Hackman, T; Balatoni, J; Finn, R; Larson, SM; Federoff, H; Blasberg, R; Fong, YM
      Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

      NATURE MEDICINE
    57. Nishizaki, M; Meyn, RE; Levy, LB; Atkinson, EN; White, RA; Roth, JA; Ji, L
      Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo

      CLINICAL CANCER RESEARCH
    58. Sadanaga, N; Nagashima, H; Mashino, K; Tahara, K; Yamaguchi, H; Ohta, M; Fujie, T; Tanaka, F; Inoue, H; Takesako, K; Akiyoshi, T; Mori, M
      Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas

      CLINICAL CANCER RESEARCH
    59. Zamboni, WC; D'Argenio, DZ; Stewart, CF; MacVittie, T; Delauter, BJ; Farese, AM; Potter, DM; Kubat, NM; Tubergen, D; Egorin, MJ
      Pharmacodynamic model of topotecan-induced time course of neutropenia

      CLINICAL CANCER RESEARCH
    60. Spiro, TP; Liu, L; Majka, S; Haaga, J; Willson, JKV; Gerson, SL
      Temozolomide: The effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O-6-alkylguanine-DNA-alkyltransferase

      CLINICAL CANCER RESEARCH
    61. Gore, SD; Weng, LJ; Zhai, S; Figg, WD; Donehower, RC; Dover, GJ; Grever, M; Griffin, CA; Grochow, LB; Rowinsky, EK; Zabalena, Y; Hawkins, EK; Burks, K; Miller, CB
      Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    62. Hartmann, F; Renner, C; Jung, W; da Costa, L; Tembrink, S; Held, G; Sek, A; Konig, J; Bauer, S; Kloft, M; Pfreundschuh, M
      Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: Role of infusion schedule and costimulation with cytokines

      CLINICAL CANCER RESEARCH
    63. Clay, TM; Hobeika, AC; Mosca, PJ; Lyerly, HK; Morse, MA
      Assays for monitoring cellular immune responses to active immunotherapy ofcancer

      CLINICAL CANCER RESEARCH
    64. von Mehren, M; Arlen, P; Gulley, J; Rogatko, A; Cooper, HS; Meropol, NJ; Alpaugh, RK; Davey, M; McLaughlin, S; Beard, MT; Tsang, KY; Schlom, J; Weiner, LM
      The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma

      CLINICAL CANCER RESEARCH
    65. Shin, DM; Donato, NJ; Perez-Soler, R; Shin, HJC; Wu, JY; Zhang, P; Lawhorn, K; Khuri, FR; Glisson, BS; Myers, J; Clayman, G; Pfister, D; Falcey, J; Waksal, H; Mendelsohn, J; Hong, WK
      Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer

      CLINICAL CANCER RESEARCH
    66. Shusterman, S; Grupp, SA; Barr, R; Carpentieri, D; Zhao, HQ; Maris, JM
      The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease

      CLINICAL CANCER RESEARCH
    67. Grem, JL; Danenberg, KD; Behan, K; Parr, A; Young, L; Danenberg, PV; Nguyen, D; Drake, J; Monks, A; Allegra, CJ
      Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the national cancer institute's anticancer drugscreen

      CLINICAL CANCER RESEARCH
    68. Xiang, R; Silletti, S; Lode, HN; Dolman, CS; Ruehlmann, JM; Niethammer, AG; Pertl, U; Gillies, SD; Primus, FJ; Reisfeld, RA
      Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice

      CLINICAL CANCER RESEARCH
    69. Schindler, J; Sausville, E; Messmann, R; Uhr, JW; Vitetta, ES
      The toxicity of deglycosylated ricin a chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: A retrospective analysis of patients in five clinical trials

      CLINICAL CANCER RESEARCH
    70. Kirstein, MN; Houghton, PJ; Cheshire, PJ; Richmond, LB; Smith, AK; Hanna, SK; Stewart, CF
      Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts

      CLINICAL CANCER RESEARCH
    71. Griffin, GM; Zhu, T; Solonenko, M; Del Piero, F; Kapakin, A; Busch, TM; Yodh, A; Polin, G; Bauer, T; Fraker, D; Hahn, SM
      Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model

      CLINICAL CANCER RESEARCH
    72. Xu, G; McLeod, HL
      Strategies for enzyme/prodrug cancer therapy

      CLINICAL CANCER RESEARCH
    73. Kelland, LR; Smith, V; Valenti, M; Patterson, L; Clarke, PA; Detre, S; End, D; Howes, AJ; Dowsett, M; Workman, P; Johnston, SRD
      Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer

      CLINICAL CANCER RESEARCH
    74. Smith, MA; Anderson, B
      Where to next with retinoids for cancer therapy?

      CLINICAL CANCER RESEARCH
    75. Cardillo, TM; Ying, ZL; Gold, DV
      Therapeutic advantage of (90)Yttrium-versus (131)Iodine-labeled PAM4 antibody in experimental pancreatic cancer

      CLINICAL CANCER RESEARCH
    76. Guichard, S; Montazeri, A; Chatelut, E; Hennebelle, I; Bugat, R; Canal, P
      Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation

      CLINICAL CANCER RESEARCH
    77. Blackstock, AW; Lightfoot, H; Case, LD; Tepper, JE; Mukherji, SK; Mitchell, BS; Swarts, SG; Hess, SM
      Tumor uptake and elimination of 2 ',2 '-difluoro-2 '-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: Correlation with in vivo tumor response

      CLINICAL CANCER RESEARCH
    78. Li, ML; Horn, L; Firby, PS; Moore, MJ
      Pharmacological determinants of 9-aminocamptothecin cytotoxicity

      CLINICAL CANCER RESEARCH
    79. Goel, A; Augustine, S; Baranowska-Kortylewicz, J; Colcher, D; Booth, BJM; Pavlinkova, G; Tempero, M; Batra, SK
      Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)

      CLINICAL CANCER RESEARCH
    80. Anderson, CP; Seeger, RC; Satake, N; Monforte-Munoz, HL; Keshelava, N; Bailey, HH; Reynolds, CP
      Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    81. Yu, DY; Dahl, GVH; Shames, RS; Fisher, PG
      Weekly dosing of carboplatin increases risk of allergy in children

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    82. Bauer, TW; Hahn, SM; Spitz, FR; Kachur, A; Glatstein, E; Fraker, DL
      Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis

      ANNALS OF SURGICAL ONCOLOGY
    83. Pirtskhalaishvili, G; Hrebinko, RL; Nelson, JB
      The treatment of prostate cancer - An overview of current options

      CANCER PRACTICE
    84. Dillman, RO
      Monoclonal antibody therapy for lymphoma - An update

      CANCER PRACTICE
    85. Kuhn, JG
      Fluorouracil and the new oral fluorinated pyrimidines

      ANNALS OF PHARMACOTHERAPY
    86. Geisler, JR; Hatterman-Zogg, MA; Rathe, JA; Lallas, TA; Kirby, P; Buller, RE
      Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP)

      HUMAN MUTATION
    87. Cunningham, CK; Wara, DW; Kang, MH; Fenton, T; Hawkins, E; McNamara, J; Mofenson, L; Duliege, AM; Francis, D; McFarland, EJ; Borkowsky, W
      Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women

      CLINICAL INFECTIOUS DISEASES
    88. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    89. McGinn, CJ; Lawrence, TS
      Recent advances in the use of radio sensitizing nucleosides

      SEMINARS IN RADIATION ONCOLOGY
    90. Berry, SE; Kinsella, TJ
      Targeting DNA mismatch repair for radiosensitization

      SEMINARS IN RADIATION ONCOLOGY
    91. Jones, HA; Hahn, SM; Bernhard, E; McKenna, WG
      Ras inhibitors and radiation therapy

      SEMINARS IN RADIATION ONCOLOGY
    92. Chmura, SJ; Gupta, N; Advani, SJ; Kufe, DW; Weichselbaum, RR
      Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation

      SEMINARS IN RADIATION ONCOLOGY
    93. Swischuk, JL; Fox, PF; Young, K; Hussain, S; Smouse, B; Castaneda, F; Brady, TM
      Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: Results and complications

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    94. Wu, CH; Yang, CH; Lee, JN; Hsu, SC; Tsai, EM
      Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    95. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    96. Ashihara, T; Namba, T; Ikeda, T; Ito, M; Kinoshita, M; Nakazawa, K
      Breakthrough waves during ventricular fibrillation depend on the degree ofrotational anisotropy and the boundary conditions: A simulation study

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    97. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    98. Chen, B; Timiryasova, TM; Gridley, DS; Andres, ML; Dutta-Roy, R; Fodor, I
      Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy

      CYTOKINE
    99. Kianmanesh, A; Hackett, NR; Lee, JM; Kikuchi, T; Korst, RJ; Crystal, RG
      Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity

      HUMAN GENE THERAPY
    100. Seiter, K; Liu, DL; Feldman, EJ; Siddiqui, AD; Hoang, A; Baskind, P; Kancherla, R; Ahmed, T
      Intravenous bolus topotecan in patients with myelodysplastic syndrome

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 08:23:26